Management of dysphagia in multiple sclerosis: current best practice

Expert Review of Gastroenterology & Hepatology
Emanuele D'AmicoSalvatore Cocuzza

Abstract

Multiple sclerosis (MS) is characterized by extreme variability in both severity and clinical course. It can show severe disabling symptoms, and among them dysphagia is frequently described. However, its management still represents a challenge in the daily care. Areas covered: In this review, we will focus on the clinical recognition and therapeutic strategies to identify and manage dysphagia in people with MS. In the view of a personalized approach, different interventions should be tailored to every single patient. Expert commentary: Multidisciplinary evaluation is mandatory in MS management, and dysphagia represents a perfect model of taking care of a disabling symptom in a chronic disease. Further research is required to better organize a personalized and long-term management of dysphagia phenomenon, through the different subtypes of MS.

References

Jan 1, 1994·The Annals of Otology, Rhinology, and Laryngology·I SchneiderH E Eckel
Apr 14, 1999·Journal of Neurophysiology·S HamdyD G Thompson
Jul 17, 2001·Dysphagia·J J HaapaniemiR J Marttila
Mar 21, 2002·Acta Neurologica Scandinavica·P CalcagnoS Paolucci
Jul 26, 2002·Clinical Neurology and Neurosurgery·A De PauwH Carton
Aug 5, 2003·The Laryngoscope·Susan G Hiss, Gregory N Postma
Apr 29, 2005·American Journal of Otolaryngology·Thomas MurryBeatriz Castillo
Jul 12, 2007·Multiple Sclerosis : Clinical and Laboratory Research·F MarrosuM G Marrosu
Feb 19, 2008·Journal of the Neurological Sciences·R BergamaschiV Cosi
Dec 18, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Cristina TassorelliGiuseppe Nappi
Dec 18, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Antonella Giusti, Marco Giambuzzi
Jan 15, 2009·The Annals of Otology, Rhinology, and Laryngology·Peter C BelafskyRebecca J Leonard
May 26, 2009·The Annals of Otology, Rhinology, and Laryngology·Hans BogaardtWytske J Fokkens
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Sep 19, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·E AlfonsiE Martignoni
Aug 25, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D A RestivoA Pavone
May 13, 2011·Nephron. Clinical Practice·Graham Woodrow, Simon Davies
Oct 9, 2012·Brain Stimulation·Domenico A RestivoAntonino Pavone
Feb 13, 2013·Acta Neurologica Scandinavica·N SchäfflerC Heesen
Apr 23, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·E AlfonsiA Moglia
Aug 10, 2013·Brazilian Journal of Otorhinolaryngology·Alessandro Murano Ferré FernandesCharles Peter Tilbery
Jun 23, 2015·Expert Review of Neurotherapeutics·Emanuele D'AmicoFrancesco Patti
Nov 17, 2015·Neurology. Neuroimmunology and Neuroinflammation·Dalia L RotsteinTanuja Chitnis
Sep 21, 2016·Neurology. Neuroimmunology and Neuroinflammation·Stephen C KriegerMadhuri Fletcher
Oct 4, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Emanuele D'AmicoFrancesco Patti
Mar 3, 2017·British Journal of Community Nursing·Nicola Bell, Lorna Brammer
Apr 4, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Hanne Marie Bøe LundeNina Grytten
Apr 5, 2017·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·D A PatelDavid O Francis
May 27, 2017·Journal of Neurogastroenterology and Motility·Selen Serel ArslanAynur A Karaduman
Aug 15, 2017·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Filomena GomesStephan C Bischoff
Aug 23, 2017·Neurology. Neuroimmunology and Neuroinflammation·Ernst-Wilhelm RadueLudwig Kappos
Sep 30, 2017·Neurology. Neuroimmunology and Neuroinflammation·Marc PawlitzkiStefanie Schreiber
Oct 23, 2017·Multiple Sclerosis and Related Disorders·Hülya Uluğut ErkoyunCumhur Ertekin
Oct 23, 2017·Multiple Sclerosis and Related Disorders·Sahar Danesh PajouhFatemeh Khanchezar
Nov 3, 2017·F1000Research·Declan Chard, S Anand Trip
Jan 11, 2018·The New England Journal of Medicine·Daniel S ReichPeter A Calabresi
Jan 21, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·X MontalbanF Zipp
Feb 13, 2018·Neurology. Neuroimmunology and Neuroinflammation·Burcu ZeydanOrhun H Kantarci
May 15, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G CosentinoG Salemi

❮ Previous
Next ❯

Citations

Feb 12, 2021·Fortschritte der Neurologie-Psychiatrie·Carolin EckardtMelanie Weinert
Feb 14, 2021·Dysphagia·Mahdi BarzegarVahid Shaygannejad
Jan 12, 2021·International Journal of MS Care·Francesca De BiagiLeonie Ruhaak
Aug 25, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Heather M ClarkJennifer L Whitwell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Gastroenterology & Hepatology
Cristina BezzioSimone Saibeni
Multiple Sclerosis : Clinical and Laboratory Research
M G GrassoE Troisi
© 2022 Meta ULC. All rights reserved